LUNG CLUSTER SEC Filing Analysis

Latest settled — T+5d ⚠ clustered

LUNG ▼ -12.35% at T+5d

NEUTRAL call ✗ call lost -12.35% · α vs SPY -9.79% · entry $1.62 → $1.42

Next anchor: T+20d in 11d

Last close $1.28 (close Jun 18) · -20.99% from $1.62 entry

Entry anchored
Jun 3, 03:59 PM ET
via Databento tick

T+1d

-5.56%

call -5.56% · α -2.97%

$1.53

settled 17d ago

T+5d

-12.35%

call -12.35% · α -9.79%

$1.42

settled 11d ago

T+20d

—

call — · α —

—

in 11d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Four Pulmonx insiders, including the CEO and General Counsel, sold a total of $34K in shares over a three-day window, while three directors received non-cash stock grants of 40,000 shares each. The sales amount to ~0.05% of the $63M market cap, well below the 0.1% threshold for materiality, and are consistent with routine tax-related or liquidity-driven selling. The non-cash grants have no economic impact. The cluster is not informative.

Key Financial Metrics

Direction

selling

Total Value

$34.0K

Insiders

4

Actionable Insight

The insider sales are immaterial in size and likely reflect routine portfolio management or tax planning. No bearish signal. Monitor upcoming quarterly results for any fundamental deterioration, but this cluster alone does not warrant action.

Key Facts

Four insiders sold shares totaling $34K (0.05% of $63M market cap)
CEO sold 13,500 shares for $21K; General Counsel sold 3,900 shares for $6K
Three directors each received 40,000 shares in non-cash grants ($0 value)
Sales occurred June 1-2, 2026; grants on June 5, 2026
No open-market purchases in the cluster

Financial Impact

Insider sales of $34K represent ~0.05% of market cap — trivial and routine

insider ownership

Risk Factors

Insider sales, while small, could precede negative news if part of a broader pattern — but no such pattern is evident here
Historical calibration shows LUNG reports have had poor T+20 predictive accuracy (33% win rate, -4.77% avg return)

Market Snapshot

Exchange

Nasdaq

Sector

Surgical & Medical Instruments & Apparatus

Analyst Consensus

73% bullish (11 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CLUSTER Data (Synthetic)	cluster-LUNG-1781042263658

8 reports for LUNG

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for LUNG — sortable, filterable
	Type				Now
Jun 3, 2026 17d ago	Insider Cluster NEUTRAL ★ 2/10	$1.62 $1.42	▼ −12.35%	▼ −9.79%	$1.28 (−20.99%)
Jun 3, 2026 17d ago	Insider Cluster NEUTRAL ★ 4/10	$1.62 $1.42	▼ −12.35%	▼ −9.79%	$1.28 (−20.99%)
Apr 22, 2026 8w ago	DEFA14A NEUTRAL ★ 3/10	$1.28 $1.20	▼ −6.25%	▼ −7.73%	$1.28 (−0.00%)
Apr 15, 2026 9w ago	Press Release NEUTRAL ★ 3/10	$1.46 $1.28	▼ −12.33%	▼ −13.31%	$1.28 (−12.33%)
Mar 5, 2026 15w ago	8-K BEARISH ★ 7/10	$1.61 $1.78	▼ −10.56%	▼ −12.80%	$1.28 (+20.50%)
Mar 4, 2026 15w ago	8-K MIXED ★ 6/10	$1.61 $1.78	▲ +10.56%	▲ +12.80%	$1.28 (−20.50%)
Mar 4, 2026 15w ago	Press Release MIXED ★ 6/10	$1.61 $1.78	▲ +10.56%	▲ +12.80%	$1.28 (−20.50%)
Mar 2, 2026 15w ago	Insider Cluster NEUTRAL ★ 2/10	$1.53 $1.82	▲ +19.34%	▲ +20.55%	$1.28 (−16.07%)

US Market Status

Market Closed — Opens Mon (29h 35m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access